No Picture
News

FDA Awards AnaBios Grant to Further Develop Preclinical Assay Using Human Primary Cardiomyocytes

SAN DIEGO, Sept. 17, 2019 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has named AnaBios the recipient of a grant to further develop its unique drug discovery platform utilizing muscle cells from the human heart (cardiomyocytes).  Fu… […]

No Picture
News

Neurocrine Biosciences Announces FDA Acceptance of New Drug Application for Opicapone as an Adjunctive Treatment for Patients with Parkinson’s Disease

– FDA Accepts New Drug Application for Opicapone, a Once-Daily, Oral, Catechol-O-Methyltransferase (COMT) Inhibitor, as Adjunctive Therapy to Levodopa/Carbidopa- Prescription Drug User Fee Act (PDUFA) Target Action Date Set for April 26, 2020- New D… […]

No Picture
News

Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2019 and Highlights Recent Corporate Progress

SAN DIEGO, May 9, 2019 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet pa… […]

No Picture
News

BioMed Realty Launches The Second Phase At Gateway of Pacific – Expanding Its Landmark Campus At The Front Door Of San Francisco’s Premier Life Science Market

BioMed Realty also closes a $430 million financing on the first phase of Gateway of Pacific after executing a long-term lease with AbbVie Inc. for 480,000 square feet

SAN DIEGO, March 20, 2019 /PRNewswire/ — BioMed Realty, a Blackstone portfolio co… […]